Mapping the receptor domains critical for the binding selectivity of delta-opioid receptor ligands.

No abstract is available for this paper.

• Publication year

  1996

• Venue

  European Journal of Pharmacology

• Publication date

  Unknown publication date

• Fields of study

  Medicine, Chemistry

• Identifiers
  PMID 8891611
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Studies on inhibition of mu and delta opioid receptor binding by dithiothreitol and N-ethylmaleimide. His223 is critical for mu opioid receptor binding and inactivation by N-ethylmaleimide.

  1996cited by this paper
• A chimeric analysis of the opioid receptor domains critical for the binding selectivity of mu opioid ligands.

  1996cited by this paper
• Irreversible Binding of cis-()-3-Methylfentanyl Isothiocyanate to the Opioid Receptor and Determination of Its Binding Domain (*)

  1996cited by this paper
• The third extracellular loop of the mu opioid receptor is important for agonist selectivity.

  1995cited by this paper
• DAMGO, a mu-opioid receptor selective agonist, distinguishes between mu- and delta-opioid receptors around their first extracellular loops.

  1995cited by this paper
• Analysis of selective binding epitopes for the kappa-opioid receptor antagonist nor-binaltorphimine.

  1995cited by this paper
• Studies on mu and delta opioid receptor selectivity utilizing chimeric and site-mutagenized receptors.

  1995cited by this paper
• A chimeric study of the molecular basis of affinity and selectivity of the kappa and the delta opioid receptors. Potential role of extracellular domains.

  1995cited by this paper
• DAMGO, a mu-opioid receptor selective ligand, distinguishes between mu-and kappa-opioid receptors at a different region from that for the distinction between mu- and delta-opioid receptors.

  1995cited by this paper
• Characterization of Irreversible Binding of -Funaltrexamine to the Cloned Rat Opioid Receptor (*)

  1995cited by this paper
• Location of Regions of the Opioid Receptor Involved in Selective Agonist Binding (*)

  1995cited by this paper
• Mutation of peptide binding site in transmembrane region of a G protein-coupled receptor accounts for endothelin receptor subtype selectivity.

  1994cited by this paper
• An opiate-receptor gene family reunion.

  1994cited by this paper
• -mu opiate receptor. Charged transmembrane domain amino acids are critical for agonist recognition and intrinsic activity.

  1994cited by this paper
• Differential binding domains of peptide and non-peptide ligands in the cloned rat kappa opioid receptor.

  1994cited by this paper
• Agonists and antagonists bind to different domains of the cloned kappa opioid receptor.

  1994cited by this paper
• Human kappa opiate receptor second extracellular loop elevates dynorphin's affinity for human mu/kappa chimeras.

  1994cited by this paper
• Structure and function of G protein-coupled receptors.

  1994cited by this paper
• A single residue, aspartic acid 95, in the delta opioid receptor specifies selective high affinity agonist binding.

  1993cited by this paper
• Molecular biology of opioid receptors.

  1993cited by this paper
• Cloning and pharmacological characterization of a rat mu opioid receptor.

  1993cited by this paper
• Primary structures and expression from cDNAs of rat opioid receptor delta- and mu-subtypes.

  1993cited by this paper
• Cloning and pharmacological characterization of a rat kappa opioid receptor.

  1993cited by this paper
• Site-directed mutagenesis of virtually any plasmid by eliminating a unique site.

  1992cited by this paper
• Mutagenesis of the beta 2-adrenergic receptor: how structure elucidates function.

  1992cited by this paper
• Delta opioid receptor radioligands.

  1992cited by this paper
• Opioid receptors and endogenous opioid peptides

  1991cited by this paper
• Regulation of the human enkephalin promoter by two isoforms of the catalytic subunit of cyclic adenosine 3',5'-monophosphate-dependent protein kinase.

  1991cited by this paper
• Multiple opioid receptors: ligand selectivity profiles and binding site signatures.

  1989cited by this paper
• High-efficiency transformation of mammalian cells by plasmid DNA.

  1987cited by this paper
• Ligand: a versatile computerized approach for characterization of ligand-binding systems.

  1980cited by this paper
• ACTH: A SHORT INTRODUCTORY REVIEW *

  1977cited by this paper

• Insights into the interaction between hemorphins and δ-opioid receptor from molecular modeling

  2024cites this paper
• The Use of Zebrafish as a Non-traditional Model Organism in Translational Pain Research: The Knowns and the Unknowns

  2021cites this paper
• Elucidating the active δ-opioid receptor crystal structure with peptide and small-molecule agonists

  2019cites this paper
• Interaction and regulatory functions of μ- and δ-opioid receptors in nociceptive afferent neurons

  2012cites this paper
• Comparative modeling of human kappa opioid receptor and docking analysis with the peptide YFa.

  2012cites this paper
• A polymorphism in exon 2 of the &dgr;‐opioid receptor affects nociception in response to specific agonists and antagonists in mice selectively bred for high and low analgesia

  2010cites this paper
• Novel delta opioid receptor agonists exhibit differential stimulation of signaling pathways.

  2009cites this paper
• Docking studies suggest ligand-specific δ-opioid receptor conformations

  2009cites this paper
• The Function of the Monomeric Form of the Mu-Opioid Receptor: G Protein- Mediated Allosteric Regulation of Agonist Binding and Stimulation of Nucleotide Exchange. Nucleotide Exchange.

  2009influential citation
• Evidence for effect of GM1 on opioid peptide conformation: NMR study on leucine enkephalin in ganglioside-containing isotropic phospholipid bicelles.

  2008cites this paper
• A unique binding epitope for salvinorin A, a non‐nitrogenous kappa opioid receptor agonist

  2006cites this paper
• Molecular recognition of opioid receptor ligands

  2006cites this paper
• Characterization of a new duplicate delta-opioid receptor from zebrafish.

  2006cites this paper
• Delta and mu opioid receptors from the brain of a urodele amphibian, the rough-skinned newt Taricha granulosa: cloning, heterologous expression, and pharmacological characterization.

  2006cites this paper
• Opioid receptor-like 1 (ORL1) molecular "road map" to understanding ligand interaction and selectivity.

  2005cites this paper
• Extending the cardioprotective window using a novel delta-opioid agonist fentanyl isothiocyanate via the PI3-kinase pathway.

  2005cites this paper
• The function of the extracellular regions in opioid receptor binding: insights from computational biology.

  2005cites this paper
• Cloning, pharmacological characterization and tissue distribution of an ORL1 opioid receptor from an amphibian, the rough-skinned newt Taricha granulosa.

  2005influential citation
• Interaction with vesicle luminal protachykinin regulates surface expression of delta-opioid receptors and opioid analgesia.

  2005cites this paper
• Construction and characterization of a kappa opioid receptor devoid of all free cysteines.

  2004cites this paper
• Opioid receptors.

  2004cites this paper
• Different regulation of human delta-opioid receptors by SNC-80 [(+)-4-[(alphaR)-alpha-((2S,5R)-4-allyl-2,5-dimethyl-1-piperazinyl)-3-methoxybenzyl]-N,N-diethylbenzamide] and endogenous enkephalins.

  2004cites this paper
• Modeling and simulation of the human delta opioid receptor.

  2004cites this paper
• Recent advances in selective opioid receptor agonists and antagonists

  2004cites this paper
• Agonist-specific regulation of the delta-opioid receptor.

  2004cites this paper
• A new cytokine: the possible effect pathway of methionine enkephalin.

  2003cites this paper
• Enhanced binding of nor‐binaltorphimine to κ‐opioid receptors in rats dependent on butorphanol

  2003cites this paper
• Enhanced binding of nor-binaltorphimine to kappa-opioid receptors in rats dependent on butorphanol.

  2003cites this paper
• Non-peptide opioid receptor ligands - recent advances. Part I - agonists.

  2002cites this paper
• Tools for dissecting signaling pathways in vivo: receptors activated solely by synthetic ligands.

  2002cites this paper
• Engineering receptors activated solely by synthetic ligands (RASSLs).

  2001cites this paper
• Comparison of the amino acid residues in the sixth transmembrane domains accessible in the binding-site crevices of mu, delta, and kappa opioid receptors.

  2001cites this paper
• Exploring the unique pharmacology of a novel opioid receptor, ZFOR1, using molecular modeling and the 'message-address' concept.

  2001cites this paper
• mu Opioid receptor: role for the amino terminus as a determinant of ligand binding affinity.

  2000cites this paper
• Pharmacological delta1- and delta2-opioid receptor subtypes in the human neuroblastoma cell line SK-N-BE: no evidence for distinct molecular entities.

  2000cites this paper
• Pharmacological profiles of selective non-peptidic delta opioid receptor ligands.

  2000cites this paper
• A δ opioid receptor lacking the third cytoplasmic loop is generated by atypical mRNA processing in human malignomas

  2000cites this paper
• Structure and regulation of opioid receptors.

  2000cites this paper
• Switching Agonist/Antagonist Properties of Opiate Alkaloids at the δ Opioid Receptor Using Mutations Based on the Structure of the Orphanin FQ Receptor*

  2000cites this paper
• The delta-opioid receptor: molecular pharmacology, signal transduction, and the determination of drug efficacy.

  1999cites this paper
• Expression of ZFOR1, a δ‐opioid receptor, in the central nervous system of the zebrafish (Danio rerio)

  1999cites this paper
• Differential G-protein activation by alkaloid and peptide opioid agonists in the human neuroblastoma cell line SK-N-BE.

  1999cites this paper
• Mutational analysis of the structure and function of opioid receptors.

  1999cites this paper
• Differential desensitization of human delta-opioid receptors by peptide and alkaloid agonists.

  1999cites this paper
• Cloning, molecular characterization, and distribution of a gene homologous to delta opioid receptor from zebrafish (Danio rerio).

  1998cites this paper
• New delta-opioid antagonists as pharmacological probes.

  1998cites this paper
• Controlling signaling with a specifically designed Gi-coupled receptor.

  1998cites this paper
• Opioid receptor three-dimensional structures from distance geometry calculations with hydrogen bonding constraints.

  1998cites this paper
• DAMGO recognizes four residues in the third extracellular loop to discriminate between mu- and kappa-opioid receptors.

  1998cites this paper
• Endogenous opioids: overview and current issues.

  1998cites this paper
• Mutagenesis of the mouse delta opioid receptor converts (-)-buprenorphine from a partial agonist to an antagonist.

  1998cites this paper
• Alpha 1-adrenergic receptor subtype determinants for 4-piperidyl oxazole antagonists.

  1998cites this paper
• Novel “Restoration of Function” Mutagenesis Strategy to Identify Amino Acids of the δ-Opioid Receptor Involved in Ligand Binding*

  1997cites this paper
• Opioid regulation of the mouse delta-opioid receptor expressed in human embryonic kidney 293 cells.

  1997cites this paper
• Moving from the Orphanin FQ Receptor to an Opioid Receptor Using Four Point Mutations*

  1996cites this paper